Aurobindo Pharma has received two approvals from Swissmedic, Government of Switzerland for the license of Amlodipine APL 5mg and 10mg tablets and Metformin APL 500mg, 850mg and 1000mg tablets.
Amlodipine APL 5mg and 10mg tablets fall under the Cardio Vascular Disorder (CVD) therapeutic segment and is indicated for the treatment of angina pectoris and mild to moderate hypertension, alone or in combination with other antihypertensives.
Metformin APL 500mg, 850mg and 1000mg tablets are a biguanide antidiabetic and indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with Type 2 diabetes mellitus.
Aurobindo now has four products approvals from Swissmedic.
Aurobindo Pharma, headquartered at Hyderabad, manufactures generic pharmaceuticals and active pharmaceuticals ingredients.